PHAR
Nexus Energy Services, Inc.
NASDAQ · Healthcare · Biotechnology · NL
$9.11
−2.67%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$9.32
From 52W high−56.99%
Volume13268.00
Market cap$644.79M
P/E (TTM)66.0x
P/S (TTM)1.8x
Div yield—
Key dataOct 19, 2026
Open
$9.32
From 52W high
−56.99%
Volume
13268.00
Market cap
$644.79M
ValuationView details →
P/E (Fwd)
55.3x
EV/EBITDA
14.1x
P/E (TTM)
66.0x
RSI (14)
33.7
MomentumView details →
1D Return
−2.67%
YTD Return
−47.23%
SummaryUpdated Jun 1, 2026
Pharming Group N.V. (NASDAQ:PHAR) is a Dutch biopharmaceutical company founded in 1988 and headquartered in Leiden, the Netherlands. The company went public on NASDAQ in December 2020 after previously trading on Euronext Amsterdam. Pharming specializes in developing and commercializing protein replacement therapies and precision medicines for rare diseases and unmet medical needs. The company has evolved from a research-focused biotechnology firm into a commercial-stage biopharmaceutical company with two marketed products and an expanding pipeline of treatments for rare genetic disorders.
Similar companies
Latest newsMore news →
No recent news for PHAR.